Modulation of proteoglycan receptor PTPσ enhances MMP-2 activity to promote recovery from multiple sclerosis

Fucheng Luo1, Amanda Phuong Tran2, Li Xin1

  • 1Department of Neurology, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA.

Nature Communications
|October 10, 2018
PubMed

Insights

Inhibiting chondroitin sulfate proteoglycans (CSPGs) and protein tyrosine phosphatase sigma (PTPσ) signaling with Intracellular Sigma Peptide (ISP) promotes myelin repair and functional recovery in animal models of Multiple Sclerosis (MS). This approach aids oligodendrocyte progenitor cell (OPC) migration and maturation.

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Multiple Sclerosis (MS) involves central nervous system (CNS) inflammation, oligodendrocyte (OL) death, and demyelination, leading to functional deficits.
  • Increased inhibitory chondroitin sulfate proteoglycans (CSPGs) in MS lesions impede myelin regeneration.
  • CSPGs exert their inhibitory effects by binding to their receptor, protein tyrosine phosphatase sigma (PTPσ), on oligodendrocyte progenitor cells (OPCs).

Purpose of the Study:

  • To investigate the role of CSPG/PTPσ signaling in failed remyelination in MS.
  • To evaluate the therapeutic potential of inhibiting CSPG/PTPσ interactions for promoting myelin repair in MS models.

Main Methods:

  • Utilized animal models of MS.
  • Administered systemically deliverable Intracellular Sigma Peptide (ISP) to inhibit CSPG/PTPσ signaling.
  • Assessed OPC migration, maturation, and remyelination.
  • Analyzed downstream molecular targets, including matrix metalloproteinase-2 (MMP-2).

Main Results:

  • Inhibition of CSPG/PTPσ signaling by ISP significantly promoted OPC migration, maturation, and remyelination in MS models.
  • ISP treatment led to functional recovery in animal models of MS.
  • PTPσ modulation resulted in the upregulation of MMP-2, facilitating CSPG digestion by OPCs.

Conclusions:

  • CSPG/PTPσ interactions critically inhibit OPCs and impede remyelination in MS.
  • Targeting CSPG/PTPσ signaling with ISP represents a promising therapeutic strategy for promoting myelin repair and functional recovery in MS.

Related Concept Videos

Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.8K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
Matrix Proteoglycans and Glycoproteins01:21

Matrix Proteoglycans and Glycoproteins

Proteoglycans are extensively glycosylated proteins, commonly found in the extracellular matrix, interwoven with collagen fibers. Hyaline cartilage, the most common type of cartilage in the body, consists of short and dispersed collagen fibers associated with large amounts of proteoglycans. These proteoglycans have long negative charges that attract cations, which in turn attract water molecules. This influx of ions and water molecules swells up the proteoglycan like a water-soaked gel that can...
5.1K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.8K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
630
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.6K